Results 21 to 30 of about 6,247,202 (205)
On α′-effects from D-branes in 4d N $$ \mathcal{N} $$ = 1
Journal of High Energy Physics, 2020 In this work we study type IIB Calabi-Yau orientifold compactifications in the presence of space-time filling D7-branes and O7-planes. In particular, we conclude that α′2 g s -corrections to their DBI actions lead to a modification of the four ...
Matthias Weissenbacher
doaj +1 more source
Results of the Childhood Cancer and Leukaemia Group's United Kingdom Relapsed Wilms Tumour Trial
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background The United Kingdom relapsed Wilms tumour (UKW‐R) trial aimed to improve the historically low survival rates after relapse of Wilms tumour (WT) through a prospective national risk‐stratified protocol. The trial also evaluated efficacy and toxicity of high‐dose melphalan.
Sucheta J. Vaidya +10 more
wiley +1 more source
SÍNTESE DE N-GLICOSILSULFONAMIDAS DERIVADAS DE D-GLICOSE E N-ACETILGLICOSAMINA
Química Nova, 2015 Herein, we report the synthesis of β-N-glycosylsulfonamides derivatives of D-glucose and N-acetylglucosamine using conventional methods. We also describe a procedure that allows the preparation of these compounds in good yields without the anomerization ...
Lucas L. Franco +3 more
doaj +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT Purpose Chemoimmunotherapy with irinotecan, temozolomide, and dinutuximab (I/T/DIN) has emerged as first‐line therapy for relapsed/refractory (r/r) high‐risk neuroblastoma (HRNB) in North America. Topotecan and cyclophosphamide (T/C) are often used in combination with dinutuximab in the setting of lack of response, progression, or incomplete ...
Benjamin J. Lerman +17 more
wiley +1 more source
Clinical Course and Impact of Breaks in Therapy for Children With Relapsed/Refractory Solid Tumors
Pediatric Blood &Cancer, EarlyView.ABSTRACT Introduction Pediatric relapsed or refractory (R/R) solid tumors carry a dismal prognosis, and postrelapse patient experiences are not well described. We present postrelapse outcomes, including number of R/R events and subsequent therapy regimens.
Matthew T. McEvoy +5 more
wiley +1 more source
N,N-Dimethyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine monohydrate
IUCrData, 2018 The asymmetric unit of the title compound, C7H9N5·H2O, consists of two formula units differing slightly in the orientation of the dimethylamino groups. In the crystal, a combination of O—H...N and N—H...O hydrogen bonds involving the water molecules of ...
Mohamed El Hafi +5 more
doaj +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background Neuropsychological complications may impair the qualitative prognosis of patients with pediatric brain tumors. However, multifaceted evaluations cannot be conducted in all patients because they are time consuming and burdensome for patients.
Ami Tabata +9 more
wiley +1 more source
Deformation of d = 4, N $$ \mathcal{N} $$ ≥ 5 supergravities breaks nonlinear local supersymmetry
Journal of High Energy Physics, 2023 We study d = 4, N $$ \mathcal{N} $$ ≥ 5 supergravities and their deformation via candidate counterterms, with the purpose to absorb UV divergences. We generalize the earlier studies of deformation and twisted self-duality constraint to the case with ...
Renata Kallosh, Yusuke Yamada
doaj +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background Patients with high‐risk neuroblastoma who either are refractory to induction chemotherapy or relapse following multi‐modal treatment have a dismal prognosis. Based on data from the BEACON trial, since 2021 the UK national guidelines recommend bevacizumab, irinotecan, and temozolomide (BIT) for patients with relapsed/refractory ...
Thomas J. Jackson +20 more
wiley +1 more source
Langues & CulturesAmagrad-a d asumer n usenfar asensegman i uselmed d ulmad n temseɛraq deg tneɣrit n tmaziɣt. Tawsit-a n yinaw i yekkin ɣer tsekla tamensayt, timawit deg tuget, yella deg-s usmeskel seg temnaḍt ɣer tayeḍ. Asegzawal n usmeskel d ttawil n uḥraz n tgemmi-ya
Yacine MEZIANI
doaj +1 more source